Skip to Content
Merck
  • Identification of iminooxothiazolidines as secreted frizzled related protein-1 inhibitors.

Identification of iminooxothiazolidines as secreted frizzled related protein-1 inhibitors.

Bioorganic & medicinal chemistry letters (2009-10-13)
Mengxiao Shi, Barbara Stauffer, Ramesh Bhat, Julia Billiard, Helga Ponce-de-Leon, Laura Seestaller-Wehr, Shoichi Fukayama, Annamarie Mangine, Robert Moran, Girija Krishnamurthy, Peter Bodine, Ariamala Gopalsamy
ABSTRACT

Secreted frizzled related protein-1 (sFRP-1) inhibitors have the potential to be used for the treatment of osteoporosis or other bone related disorders, since the level of sFRP-1 affects osteoblast apoptosis and proliferation. From high throughput screening, we have identified a class of iminooxothiazolidines as sFRP-1 inhibitors. Structure-activity relationships were established for various regions of the scaffold along with the biochemical characterization of this class to probe selectivity, binding and ex vivo activity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
EU1794-4, ≥98% (HPLC)